Cases 101 - 110 of 335
CESAR CASTILLO, INC. v. FOUGERA PHARMACEUTICALS, INC. et al
as 2:2017cv01668
Plaintiff:
CESAR CASTILLO, INC.
Defendant:
FOUGERA PHARMACEUTICALS, INC., NOVARTIS AG, SANDOZ, INC. and others
Cause Of Action: 15 U.S.C. § 15
FWK HOLDINGS, L.L.C. v. FOUGERA PHARMACEUTICALS, INC. et al
as 2:2017cv01662
Plaintiff:
FWK HOLDINGS, L.L.C.
Defendant:
FOUGERA PHARMACEUTICALS, INC. , SANDOZ, INC. , NOVARTIS AG and others
Cause Of Action: 15 U.S.C. § 1
FWK HOLDINGS, L.L.C. v. FOUGERA PHARMACEUTICALS, INC. et al
as 2:2017cv01663
Plaintiff:
FWK HOLDINGS, L.L.C.
Defendant:
FOUGERA PHARMACEUTICALS, INC. , SANDOZ, INC. , NOVARTIS AG and others
Cause Of Action: 15 U.S.C. § 2
Novartis Pharmaceuticals Corporation et al v Mylan Pharmaceuticals Inc.
as 1:2017cv00054
Plaintiff:
Novartis Pharmaceuticals Corporation and Novartis AG
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation et al v. Teva Pharmaceuticals USA, Inc.
as 1:2017cv00393
Plaintiff:
Novartis Pharmaceuticals Corporation and Novartis AG
Defendant:
Teva Pharmaceuticals USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation et al v. Mylan Pharmaceuticals Inc.
as 1:2017cv00389
Plaintiff:
Novartis Pharmaceuticals Corporation and Novartis AG
Defendant:
Mylan Pharmaceuticals Inc.
Counter_claimant:
Mylan Pharmaceuticals Inc.
Counter_defendant:
Novartis AG and Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Alembic Pharmaceuticals Limited v. Novartis AG et al
as 1:2017cv00292
Plaintiff:
Alembic Pharmaceuticals Limited
Defendant:
Novartis AG and Mitsubishi Tanabe Pharma Corporation
Cause Of Action: 35 U.S.C. § 1
NOVARTIS AG et al v. AUROBINDO PHARMA LTD. et al
as 2:2017cv00389
Plaintiff:
NOVARTIS AG , NOVARTIS PHARMACEUTICALS CORPORATION , MITSUBISHI TANABE PHARMA CORPORATION and others
Defendant:
AUROBINDO PHARMA LTD. and AUROBINDO PHARMA USA, INC.
Cause Of Action: 15 U.S.C. § 1126
Novartis AG et al v. Aurobindo Pharma Ltd. et al
as 1:2017cv00048
Plaintiff:
Novartis AG , Novartis Pharmaceuticals Corporation , Mitsubishi Tanabe Pharma Corporation and others
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 145
Cesar Castillo, Inc. v. Sandoz, Inc. et al
as NYS/1:16-cv-09949
Plaintiff:
Cesar Castillo, Inc.
Defendant:
Sandoz, Inc. , Novartis AG , Lannett Company, Inc. and others
Movant:
Rochester Drug Co-Operative, Inc.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
